Similarly, prostate specific antigen (PSA), a tissue-specific serum protein that is used in the diagnosis of prostate cancer, is also commonly increased in sera of patients with benign prostatic hyperplasia, thus, posing difficulties in clinically differentiating the two different conditions (Barry, 2001; Thompson et al., 2004). This evidence concerns the gene KLK3 and prostate carcinoma.